Webinar: Enhance the translatability of the immune/efficacy-related effects of biologics using one humanized mouse model, October 20, 2026

genOway presentation

Event
-
October 20, 2026

genOway’s live webinar

‍

Tuesday, October 20, 2026 - 5:30 pm CET / 11:30 am EST / 8:30 am PST

Presenter: Fabiane Sônego, PhD, Director of Preclinical Models and Services at genOway

Title: "Enhance the translatability of the immune/efficacy-related effects of biologics using one humanized mouse model"

Presentation highlights:

  • genO-BRGSF-HIS mice recapitulate key CRS features induced by biologics tested in the clinic
  • Immune cells are recruited, polarized and activated in the tumor microenvironment in genO-BRGSF-HIS mice
  • genO-BRGSF-HIS enables the assessment of both efficacy and safety in a single model

Register here!‍

Other news & events

The 55th Annual Meeting of the Japanese Society for Immunology, Osaka, November 17-19, 2026
Conference
genOway presentation
Event
-
Nov 2026
Read on
18th annual PEGS Europe, Lisbon, Portugal, November 16-19, 2026
Conference
genOway presentation
Event
-
Nov 2026
Read on
SITC meeting 2026, Phoenix, Arizona, November 4-8
Conference
genOway presentation
Event
-
Nov 2026
Read on
Webinar: Derisking a PD-L1 Targeting T-cell Engager with Preclinical Mouse Models, November 3, 2026
genOway presentation
Event
-
Nov 2026
Read on
2nd T-Cell Engager for Autoimmune Disease Summit, Boston, October 27-29, 2026
Conference
genOway presentation
Event
-
Oct 2026
Read on
Scientific excellence

From model design to experimental results
Featured in 600+ scientific articles

Collaborative approach

Collaboration with 17 Top Pharmas,
170+ Biotechs and 380+ Academic Institutions

Robust validation data on catalog models

Generated with biopharma partners and in-house

Innovative technologies

and guaranteed freedom to operate

Easy access to models

Models with certified health status from professional breeders in US and Europe